Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Return on Invested Capital (2022 - 2025)

Sunshine Biopharma (SBFM) has disclosed Return on Invested Capital for 4 consecutive years, with 0.24% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 3.0% year-over-year to 0.24%, compared with a TTM value of 0.24% through Sep 2025, down 3.0%, and an annual FY2024 reading of 0.25%, changed 0.0% over the prior year.
  • Return on Invested Capital was 0.24% for Q3 2025 at Sunshine Biopharma, up from 0.26% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.19% in Q2 2024 and bottomed at 1.36% in Q1 2023.
  • Average Return on Invested Capital over 4 years is 0.55%, with a median of 0.24% recorded in 2023.
  • The sharpest move saw Return on Invested Capital surged 115bps in 2024, then dropped -8bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.88% in 2022, then skyrocketed by 72bps to 0.24% in 2023, then rose by 6bps to 0.23% in 2024, then fell by -4bps to 0.24% in 2025.
  • Business Quant data shows Return on Invested Capital for SBFM at 0.24% in Q3 2025, 0.26% in Q2 2025, and 0.24% in Q1 2025.